|
|
|
Insider
Information: |
Hallal David |
Relationship: |
Director |
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
2,992,151 |
|
Indirect Shares
|
17,647,006 |
|
|
Direct
Value |
$38,846,310 |
|
|
Indirect Value
|
$34,343,989 |
|
|
Total
Shares |
20,639,157 |
|
|
Total
Value |
$73,190,298 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-122.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
CEO, Director |
2016-08-08 |
189,266 |
2014-12-18 |
113,122 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
|
2024-06-27 |
304,095 |
2019-09-18 |
0 |
Premium* |
|
Allovir Inc |
ALVR |
|
2024-06-06 |
2,143,662 |
2024-06-06 |
17,533,884 |
Premium* |
|
Seer, Inc. |
SEER |
|
2024-06-12 |
355,128 |
|
0 |
Premium* |
|
Iteos Therapeutics, Inc. |
ITOS |
Director |
2022-06-09 |
0 |
2021-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
Sr. VP Comm. Ops, Americas |
|
2009-06-11 |
4 |
S |
$38.00 |
$136,420 |
D/D |
(3,590) |
19,910 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr. VP Comm Ops, Americas |
|
2009-06-19 |
4 |
S |
$38.47 |
$30,353 |
D/D |
(789) |
19,121 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr. VP Comm Ops, Americas |
|
2009-07-16 |
4 |
S |
$38.96 |
$9,272 |
D/D |
(238) |
18,883 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr. VP Comm Ops, Americas |
|
2009-07-27 |
4 |
S |
$43.00 |
$371,520 |
D/D |
(8,640) |
10,243 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2009-12-11 |
4 |
S |
$46.40 |
$464,000 |
D/D |
(10,000) |
10,243 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2009-12-11 |
4 |
OE |
$16.32 |
$163,200 |
D/D |
10,000 |
20,243 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2009-12-21 |
4 |
S |
$47.79 |
$43,776 |
D/D |
(916) |
9,327 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-01-11 |
4 |
S |
$47.78 |
$51,985 |
D/D |
(1,088) |
8,239 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-01-19 |
4 |
S |
$47.22 |
$10,719 |
D/D |
(227) |
8,012 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
14,012 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-02-16 |
4 |
S |
$47.93 |
$299,179 |
D/D |
(6,242) |
7,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-03-02 |
4 |
S |
$51.80 |
$518,000 |
D/D |
(10,000) |
7,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-03-02 |
4 |
OE |
$16.32 |
$163,200 |
D/D |
10,000 |
17,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-06-21 |
4 |
S |
$54.81 |
$50,206 |
D/D |
(916) |
6,854 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-07-12 |
4 |
S |
$51.91 |
$12,355 |
D/D |
(238) |
6,616 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-07-16 |
4 |
S |
$51.08 |
$11,595 |
D/D |
(227) |
6,389 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-11-03 |
4 |
S |
$70.42 |
$184,446 |
D/D |
(2,619) |
3,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-11-04 |
4 |
OE |
$16.32 |
$326,400 |
D/D |
20,000 |
23,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-11-04 |
4 |
S |
$70.29 |
$1,405,800 |
D/D |
(20,000) |
3,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-12-14 |
4 |
OE |
$16.32 |
$81,600 |
D/D |
5,000 |
8,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-12-15 |
4 |
S |
$79.33 |
$1,080,157 |
D/D |
(13,616) |
8,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-12-15 |
4 |
OE |
$16.32 |
$222,213 |
D/D |
13,616 |
22,386 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-12-27 |
4 |
OE |
$16.32 |
$40,800 |
D/D |
2,500 |
11,270 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-01-10 |
4 |
S |
$81.27 |
$21,862 |
D/D |
(269) |
11,001 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Commercial Ops |
|
2011-01-18 |
4 |
S |
$82.66 |
$20,252 |
D/D |
(245) |
10,756 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|